FDA Inspection 605450 — Labomar Canada Inc

Labomar Canada Inc — FEI 3000999767

The FDA completed an inspection of Labomar Canada Inc on Aug 13, 2009 in Pointe-Claire. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 13, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pointe-Claire (Canada)

Citations

IDCFRDescription
163021 CFR 211.130(b)Unlabeled filled containers controls
178721 CFR 211.80(a)Procedures To Be in Writing
197621 CFR 211.182Specific information required in individual logs
430321 CFR 211.67(b)Written procedures fail to include